Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8459383 | Radiotherapy and Oncology | 2017 | 10 Pages |
Abstract
For previously irradiated patients with recurrent pelvic disease, SABR re-irradiation could be a feasible intervention for those who otherwise have limited options. Evidence to support this technique is limited but shows initial promise. Based on the available literature, suggestions for a more formal SABR re-irradiation pathway are proposed. Prospective studies and a multidisciplinary approach are required to optimise future treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Louise Janet Murray, John Lilley, Maria A. Hawkins, Ann M. Henry, Peter Dickinson, David Sebag-Montefiore,